Diagnosis of Anti-Angiogenesis Peptide Binding to HUVECs Using FITC

Background & aim: Angiogenesis is the production of new blood vessels from existing vessels. Angiogenesis depends on the balance between its activating and inhibitory factors. Endostatin, a 20-kDa fragment of collagen XVIII, is a member of the angiogenesis inhibitory protein group that inhibits...

Full description

Bibliographic Details
Main Authors: M Shourian, SM Asghari, F Amini Sepehr
Format: Article
Language:fas
Published: Yasuj University Of Medical Sciences 2019-09-01
Series:Armaghane Danesh Bimonthly Journal
Subjects:
Online Access:http://armaghanj.yums.ac.ir/article-1-2495-en.html
_version_ 1828222442518085632
author M Shourian
SM Asghari
F Amini Sepehr
author_facet M Shourian
SM Asghari
F Amini Sepehr
author_sort M Shourian
collection DOAJ
description Background & aim: Angiogenesis is the production of new blood vessels from existing vessels. Angiogenesis depends on the balance between its activating and inhibitory factors. Endostatin, a 20-kDa fragment of collagen XVIII, is a member of the angiogenesis inhibitory protein group that inhibits endothelial cell proliferation and migration and tubular-like structure. The use of colorimetric methods by fluorescent probes as a tracer is widespread, so the aim of this study was to determine and detect the binding of anti-angiogenic peptide to human cord endothelial cells using a fluorescence marker.   Methods: In the present experimental study, the 27 amino acid fragment of the endostatin protein amino acid domain was labeled with FITC as a fluorescence marker. Gel filtration chromatography with Sephadex G10 was used to separate the bound peptides and finally FTIR method was used to confirm the binding of FITC to the peptide. Human umbilical cord endothelial cells were treated with marker-bound peptides after culturing and studied by fluorescence microscopy to observe peptide binding to their receptor on the surface of these cells.   Results: findings by Fluorescence microscopy confirmed binding antiangiogenic peptide to its specific receptor. Various conditions such as concentration, time, and temperature were tested to achieve the proper conditions for marking peptides. Unlabeled FITCs separated by gel filtration Chromatography method with sephedex G10. Human umbilical endothelial cells (HUVECs) are harvested and treated with conjugate samples (FITC-peptide) from gel filtration chromatography. After the required time, the cells were fixed and the binding of labeled peptides to their receptors on HUVECs was analyzed by Fluorescence microscope.   Conclusion: The results of fluorescence microscopy confirmed the binding of this antiangiogenic peptide to its specific receptor on endothelial cells. Different experimental conditions such as peptide concentration and FITC and incubation time and temperature were studied to obtain the appropriate conditions for peptide labeling. Free FITCs were separated by conjugated FITC-peptide samples by gel filtration chromatography. Human umbilical cord endothelial cells (HUVEC) cultured with FITC-peptide conjugated samples were treated. The cells were then fixed and examined by fluorescence microscopy.
first_indexed 2024-04-12T16:54:39Z
format Article
id doaj.art-64d6da080d884f67b052efbf36c77cab
institution Directory Open Access Journal
issn 1728-6514
1728-6514
language fas
last_indexed 2024-04-12T16:54:39Z
publishDate 2019-09-01
publisher Yasuj University Of Medical Sciences
record_format Article
series Armaghane Danesh Bimonthly Journal
spelling doaj.art-64d6da080d884f67b052efbf36c77cab2022-12-22T03:24:17ZfasYasuj University Of Medical SciencesArmaghane Danesh Bimonthly Journal1728-65141728-65142019-09-01244691709Diagnosis of Anti-Angiogenesis Peptide Binding to HUVECs Using FITCM Shourian0SM Asghari1F Amini Sepehr2 Department of biology, Faculty of Sciences, University of Guilan, Rasht, Iran Department of biology, Faculty of Sciences, University of Guilan, Rasht, Iran Department of biology, Faculty of Sciences, University of Guilan, Rasht, Iran Background & aim: Angiogenesis is the production of new blood vessels from existing vessels. Angiogenesis depends on the balance between its activating and inhibitory factors. Endostatin, a 20-kDa fragment of collagen XVIII, is a member of the angiogenesis inhibitory protein group that inhibits endothelial cell proliferation and migration and tubular-like structure. The use of colorimetric methods by fluorescent probes as a tracer is widespread, so the aim of this study was to determine and detect the binding of anti-angiogenic peptide to human cord endothelial cells using a fluorescence marker.   Methods: In the present experimental study, the 27 amino acid fragment of the endostatin protein amino acid domain was labeled with FITC as a fluorescence marker. Gel filtration chromatography with Sephadex G10 was used to separate the bound peptides and finally FTIR method was used to confirm the binding of FITC to the peptide. Human umbilical cord endothelial cells were treated with marker-bound peptides after culturing and studied by fluorescence microscopy to observe peptide binding to their receptor on the surface of these cells.   Results: findings by Fluorescence microscopy confirmed binding antiangiogenic peptide to its specific receptor. Various conditions such as concentration, time, and temperature were tested to achieve the proper conditions for marking peptides. Unlabeled FITCs separated by gel filtration Chromatography method with sephedex G10. Human umbilical endothelial cells (HUVECs) are harvested and treated with conjugate samples (FITC-peptide) from gel filtration chromatography. After the required time, the cells were fixed and the binding of labeled peptides to their receptors on HUVECs was analyzed by Fluorescence microscope.   Conclusion: The results of fluorescence microscopy confirmed the binding of this antiangiogenic peptide to its specific receptor on endothelial cells. Different experimental conditions such as peptide concentration and FITC and incubation time and temperature were studied to obtain the appropriate conditions for peptide labeling. Free FITCs were separated by conjugated FITC-peptide samples by gel filtration chromatography. Human umbilical cord endothelial cells (HUVEC) cultured with FITC-peptide conjugated samples were treated. The cells were then fixed and examined by fluorescence microscopy.http://armaghanj.yums.ac.ir/article-1-2495-en.htmlantiangiogenic peptidefluorescein isothiocyanathuman umbilical endothelial cells (huvecs)
spellingShingle M Shourian
SM Asghari
F Amini Sepehr
Diagnosis of Anti-Angiogenesis Peptide Binding to HUVECs Using FITC
Armaghane Danesh Bimonthly Journal
antiangiogenic peptide
fluorescein isothiocyanat
human umbilical endothelial cells (huvecs)
title Diagnosis of Anti-Angiogenesis Peptide Binding to HUVECs Using FITC
title_full Diagnosis of Anti-Angiogenesis Peptide Binding to HUVECs Using FITC
title_fullStr Diagnosis of Anti-Angiogenesis Peptide Binding to HUVECs Using FITC
title_full_unstemmed Diagnosis of Anti-Angiogenesis Peptide Binding to HUVECs Using FITC
title_short Diagnosis of Anti-Angiogenesis Peptide Binding to HUVECs Using FITC
title_sort diagnosis of anti angiogenesis peptide binding to huvecs using fitc
topic antiangiogenic peptide
fluorescein isothiocyanat
human umbilical endothelial cells (huvecs)
url http://armaghanj.yums.ac.ir/article-1-2495-en.html
work_keys_str_mv AT mshourian diagnosisofantiangiogenesispeptidebindingtohuvecsusingfitc
AT smasghari diagnosisofantiangiogenesispeptidebindingtohuvecsusingfitc
AT faminisepehr diagnosisofantiangiogenesispeptidebindingtohuvecsusingfitc